BNTC (Benitec Biopharma) Total Assets: $187.00 Mil (As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $12.35
View Full Analysis

What is Benitec Biopharma Total Assets?

Benitec Biopharma BNTC -4.77% 34 Total Assets is $187.00 Mil as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

Benitec Biopharma's Total Assets for the quarter that ended in Mar. 2026 was $187.00 Mil.

During the past 12 months, Benitec Biopharma's average Total Assets Growth Rate was 37.70% per year. During the past 3 years, the average Total Assets Growth Rate was -1.10% per year. During the past 5 years, the average Total Assets Growth Rate was -0.90% per year. During the past 10 years, the average Total Assets Growth Rate was -5.40% per year.

During the past 12 years, Benitec Biopharma's highest 3-Year average Total Assets Growth Rate was 42.40%. The lowest was -25.10%. And the median was -1.10%.

Total Assets is connected with ROA %. Benitec Biopharma's annualized ROA % for the quarter that ended in Mar. 2026 was -25.28%. Total Assets is also linked to Revenue through Asset Turnover. Benitec Biopharma's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Benitec Biopharma  (NAS:BNTC) Total Assets Explanation

Total Assets is connected with ROA %.

Benitec Biopharma's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-47.74/( (190.681+187)/ 2 )
=-47.74/188.8405
=-25.28 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Benitec Biopharma's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (190.681+187)/ 2 )
=0/188.8405
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Benitec Biopharma Total Assets Related Terms

Benitec Biopharma Total Assets Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Total Assets Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.38 5.97 4.46 52.21 99.59

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.21 99.59 96.03 190.68 187.00
BNTC
34GF Score
Benitec Biopharma Inc BNTC
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Benitec Biopharma's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=97.295+2.297
=99.59

Benitec Biopharma's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=183.332+3.668
=187.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $187.00 Mil mean?
Benitec Biopharma (BNTC) has a Total Assets of $187.00 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Total Assets too high?
Benitec Biopharma's current Total Assets is $187.00 Mil. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Total Assets compare to OABI and FBRX?
Benitec Biopharma's Total Assets of $187.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Total Assets is $187.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Total Assets of $187.00 Mil. The current Total Assets is $187.00 Mil. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Total Assets is $187.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.35
Price